Nanalyze

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/H34H_m_K3tY.

CRSP Stock is currently the biggest gene editing stock by market cap and the one likely to have the first gene editing therapy approved and marketed. Exa-cel is pending a decision on December 8th for sickle cell disease or SCD and March 2024 for transfusion dependent beta thalassemia or TDT. A recent report looked at pricing exa-cel and lovo-cel, a gene therapy by Bluebird Bio that will also provide a cure for SCD. Both therapies have been given a "fair price estimate" midpoint of $1.7 million so we can now start estimating what cash flows might look like for the 25,000 eligible SCD patients and 7,000 eligible TDT patients. Investors in CRSP stock need to temper their expectations as there are quite a few unknowns remaining. If the exa-cel approval next month makes $CRSP stock move in either direction, expect that tide to move all gene editing stocks. The next gene editing stock to watch for an approved treatment should be Intellia. If you're invested in CRISPR Therapeutics stock, this video is a much-watch.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/e_baO4jpdyw.

Solar stocks have been plummeting as evident by the nearly 40% year-to-date drop of the largest solar ETF, TAN. The three largest solar stocks - Enphase, SolarEdge and First Solar - are showing mixed results. While SEDG and ENPH are down 70% since the start of the year, FSLR is up 1%. That's mainly because the two largest producers of inverters have seen revenues plummet as numerous solar projects are being canceled because of higher interest rates. Digging into SolarEdge, the situation appears a lot worse than it actually it, at least according to management which expects things to recover slowly over a few quarters. Enphase appears to be in better shape with margins staying in the 40s while SolarEdge expects them to fall to single digits next quarter. That's mainly because fixed costs take time to catch up with declining revenues, or so we're told. If you're invested in solar stocks, or thinking about going long here, this is the video to watch.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/UNmxIOrhWUI.

Tesla stock can be overvalued or undervalued. It just depends on what benchmark you want to use. Since Tesla has more growth than value, we compared the company's simple valuation ratio (7) to the top ten largest companies in the world (average is 8). That doesn't prove Tesla stock is undervalued because we need to compare apples to apples which is what Tesla does today compared to other companies in the same business. Right now Tesla is an automaker with quite good gross margins compared to the competition. Those of you who love price targets will be interested to know that Tesla would trade under $20 a share were it valued the same as competitors like Ford or General Motors. Those latter two names represent companies with a massive amount of debt that had problems navigating the 2008 financial crisis. Tesla is in much better shape with a strong net cash position and little debt. The reason investors are overvaluing Tesla stock is because they see a company that may be able to use generative AI to solve the autonomous driving problem - it's ARK Invest's robotaxi thesis that sees Tesla shares hitting $2,000 by 2027. Love Elon Musk or hate him, our video on Tesla's valuation will teach you something.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/LDKphIvWZs4.

Palantir stock vs Snowflake stock. It’s a heated debate for investors in the former who always claim nobody understands their sacred cow and that any sort of comparison is apples to oranges. Let’s put all that aside and start with the commonalities. These are two SaaS firms selling solutions to large companies that create efficiencies and benefit from the dramatic growth of big data. We examine metrics that both companies have in common such as revenue growth, net retention rates, and gross margins. There’s no reason investors need to choose between PLTR stock and SNOW stock. Invest in both or neither. Like women, we all have different tastes, and if we’re going to choose one to stick with for a long time, we want to be focused on red flags, not exciting growth stories spun by media-trained executives. If you’re an investor in Palantir Stock or Snowflake Stock, you’ll want to watch this analysis.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/fv1NCFj_zvo.

A great dividend portfolio will be diversified across sectors/industries to help provide stability and consistency. Dividend growth stocks are inherently larger and less volatile, so the question becomes how many dividend growth stocks to hold? The answer is at least 10, and ideally 15 according to the venerable CFA institute. We're holding 30 DGO stocks because we'd like to ultimately build an ETF off our Quantigence strategy. To do so, we need a systematic method of trimming our positions to ensure a relatively equal weight across our dividend stock portfolio. After a thorough review of the academic research out there, we believe that a value-weighted dividend portfolio trimmed using a quarterly systematic method is the optimal configuration.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/qSYP9v0rydM

We look at 5 robotic surgery stocks that have a market cap greater than $100 million. Accuracy deals in radiation so isn't robotic surgery in the strictest sense of the term. Stereotaxis isn't enjoying revenue growth, so they're not worth pursuing until that happens. Globus Medical is hardly a pure play, while Procept BioRobotics doesn't seem to have as large an opportunity as they think. That brings us to Intuitive Surgical ISRG which is a leader in surgical robotics and certainly worth a closer look - at the right valuation that is.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/x6NKjvGo8Zc.

SPCE stock or Virgin Galactic stock is a popular space stock that is making a big bet on space tourism. Our SPCE stock video looks at how far behind schedule the company is as they bring their first tourists to space in 2023. A regular cadence of flights should help them start to get through the 800 ticket backlog of people who are willing to spend hundreds of thousands of dollars for a two-hour flight into space. Here's why $SPCE stock is a space stock we think should be avoided. PS: If the company goes bankrupt, that means that the business becomes less attractive, contrary to what all the lumps of lead out there will say.

Caterpillar stock or CAT stock is a dividend champion (also called a dividend aristocrat) that has a diversified industrial business with a safe dividend that's grown nearly 10% over the past decade. Many CAT investors probably don't realize how many types of equipment and engines Caterpillar builds. Around 60% of CAT's revenues come from outside the United States providing some great international diversification. It's a member of the Dow Jones Industrial Average (we cover what that is) and provides a diversified way to play the industrial sector. We'd consider CAT stock as a replacement for MMM stock, the latter which is running into problems with a mass tort money grab led by gravy-sucking attorneys with no integrity who are humored by judges who see no problem in driving one of America's most innovative companies - and most notable dividend champions - straight into the ground.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/FwHaJv31T0I.

Financial advice for kids doesn't have to be stuffy and boring. There are three things your kids need to learn about when it comes to basic financial literacy - making money, saving money, and generating a return on money. Those are listed in order of importance, so they need to figure out a career that makes decent money. Whenever or however they start accumulating money, they need to start saving money because the time value of money is the single most important factor when it comes to accumulating wealth. Saving money happens more easily living below your means and distinguishing between needs vs wants. You need a car, but you want an expensive car, for example. Teaching kids about money early on instills good money management habits that will last a lifetime. Probably the most important asset a kid will ever have is their work ethic. If you want to be rich, you'll need to work for it. It's much easier than you might think to become a millionaire, but you see so few of them because most people lack the discipline and patience required to properly accumulate wealth. Teaching kids about money starts with this video.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/Iu0t2_QrFgw.

The latest Tesla stock earnings call sent shares falling as investors tried to digest all the pessimism coming from Elon Musk, a man who has managed to tackle some of the toughest problems using first principles thinking, and who sees tough problems left to tackle when bringing the Cybertruck to production. Tesla investors need to focus on the company's objectives which focus on lowering COGS and generating healthy operating cash flows to further invest in the business. Overall Tesla's earnings call wasn't anything long-term investors should concern themselves with. Where the company really needs to prove itself is in all the grand claims being made of Tesla being the dominant AI hardware company in the world with autonomous cars and humanoid robots. We shall see. And If you're looking for a Tesla price prediction, we can't help right now. Our Romanian fortune teller is on holiday in Transnistria.